The prognostic role of key factors in renal cell carcinoma with bone metastases

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective analysis identifies survival influences in mRCC patients with bone metastases, suggesting individualized treatment strategies.

Complete metastasectomy significantly improves survival rates in patients with renal cell carcinoma with bone metastases.
Five-year overall survival rates were 80% for solitary metastases, while high mortality was linked to diffuse metastases.
Systemic therapies showed limited survival benefits, emphasizing the importance of a multidisciplinary treatment approach.
The MSKCC and IMDC scores did not independently predict overall survival in this patient group.

Erdoğan et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective analysis identifies survival influences in mRCC patients with bone metastases, suggesting individualized treatment strategies.